BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34360828)

  • 1. Benzo[
    Dračínská H; Indra R; Jelínková S; Černá V; Arlt VM; Stiborová M
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to endocrine disruptors 17alpha-ethinylestradiol and estradiol influences cytochrome P450 1A1-mediated genotoxicity of benzo[a]pyrene and expression of this enzyme in rats.
    Stiborová M; Dračínská H; Bořek-Dohalská L; Klusoňová Z; Holecová J; Martínková M; Schmeiser HH; Arlt VM
    Toxicology; 2018 May; 400-401():48-56. PubMed ID: 29649501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between DNA adduct formation by benzo[a]pyrene and expression of its activation enzyme cytochrome P450 1A1 in rat.
    Hodek P; Koblihová J; Kizek R; Frei E; Arlt VM; Stiborová M
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):989-96. PubMed ID: 24095716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome b5 and epoxide hydrolase contribute to benzo[a]pyrene-DNA adduct formation catalyzed by cytochrome P450 1A1 under low NADPH:P450 oxidoreductase conditions.
    Stiborová M; Moserová M; Černá V; Indra R; Dračínský M; Šulc M; Henderson CJ; Wolf CR; Schmeiser HH; Phillips DH; Frei E; Arlt VM
    Toxicology; 2014 Apr; 318():1-12. PubMed ID: 24530354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice.
    Krais AM; Speksnijder EN; Melis JP; Indra R; Moserova M; Godschalk RW; van Schooten FJ; Seidel A; Kopka K; Schmeiser HH; Stiborova M; Phillips DH; Luijten M; Arlt VM
    Arch Toxicol; 2016 Apr; 90(4):839-51. PubMed ID: 25995008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced expression of cytochrome P450 1A and NAD(P)H:quinone oxidoreductase determined at mRNA, protein, and enzyme activity levels in rats exposed to the carcinogenic azo dye 1-phenylazo-2-naphthol (Sudan I).
    Stiborová M; Dračínská H; Martínek V; Svášková D; Hodek P; Milichovský J; Hejduková Ž; Brotánek J; Schmeiser HH; Frei E
    Chem Res Toxicol; 2013 Feb; 26(2):290-9. PubMed ID: 23289503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidation of carcinogenic benzo[a]pyrene by human and rat cytochrome P450 1A1 and its influencing by cytochrome b5 - a comparative study.
    Indra R; Moserova M; Sulc M; Frei E; Stiborova M
    Neuro Endocrinol Lett; 2013; 34 Suppl 2():55-63. PubMed ID: 24362093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of individual cytochrome P450 enzymes on oxidative metabolism of benzo[a]pyrene in human livers.
    Šulc M; Indra R; Moserová M; Schmeiser HH; Frei E; Arlt VM; Stiborová M
    Environ Mol Mutagen; 2016 Apr; 57(3):229-35. PubMed ID: 26919089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudan I is a potential carcinogen for humans: evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes.
    Stiborová M; Martínek V; Rýdlová H; Hodek P; Frei E
    Cancer Res; 2002 Oct; 62(20):5678-84. PubMed ID: 12384524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to benzo[a]pyrene of Hepatic Cytochrome P450 Reductase Null (HRN) and P450 Reductase Conditional Null (RCN) mice: Detection of benzo[a]pyrene diol epoxide-DNA adducts by immunohistochemistry and 32P-postlabelling.
    Arlt VM; Poirier MC; Sykes SE; John K; Moserova M; Stiborova M; Wolf CR; Henderson CJ; Phillips DH
    Toxicol Lett; 2012 Sep; 213(2):160-6. PubMed ID: 22759596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
    Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
    Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene.
    Harrigan JA; McGarrigle BP; Sutter TR; Olson JR
    Toxicol In Vitro; 2006 Jun; 20(4):426-38. PubMed ID: 16198082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2.
    Arlt VM; Hewer A; Sorg BL; Schmeiser HH; Phillips DH; Stiborova M
    Chem Res Toxicol; 2004 Aug; 17(8):1092-101. PubMed ID: 15310241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzo[a]pyrene-induced toxicity: paradoxical protection in Cyp1a1(-/-) knockout mice having increased hepatic BaP-DNA adduct levels.
    Uno S; Dalton TP; Shertzer HG; Genter MB; Warshawsky D; Talaska G; Nebert DW
    Biochem Biophys Res Commun; 2001 Dec; 289(5):1049-56. PubMed ID: 11741297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dihydromyricetin on benzo[a]pyrene activation in rats.
    Hodek P; Fousova P; Brabencova E; Moserova M; Pavek P; Anzenbacherova E; Brotanek J; Hudecek J; Frei E; Stiborova M
    Neuro Endocrinol Lett; 2014; 35 Suppl 2():158-68. PubMed ID: 25638381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of benzo(a)pyrene biotransformation by resveratrol in Apc
    Huderson AC; Rekha Devi PV; Niaz MS; Adunyah SE; Ramesh A
    Invest New Drugs; 2019 Apr; 37(2):238-251. PubMed ID: 29931584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of beta-naphthoflavone on genotoxicity of food-derived carcinogens.
    Hodek P; Krizkova J; Frei E; Singh R; Arlt VM; Stiborova M
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():25-34. PubMed ID: 22167217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of low-level short-term o-xylene inhalation of benzo[a]pyrene (BaP) metabolism and BaP-DNA adduct formation in rat liver and lung microsomes.
    Park SH; Schatz RA
    J Toxicol Environ Health A; 1999 Nov; 58(5):299-312. PubMed ID: 10598955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA adduct formation in precision-cut rat liver and lung slices exposed to benzo[a]pyrene.
    Harrigan JA; Vezina CM; McGarrigle BP; Ersing N; Box HC; Maccubbin AE; Olson JR
    Toxicol Sci; 2004 Feb; 77(2):307-14. PubMed ID: 14691214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of chrysoeriol on DNA adduct formation with benzo[a]pyrene in MCF-7 breast cancer cells.
    Takemura H; Nagayoshi H; Matsuda T; Sakakibara H; Morita M; Matsui A; Ohura T; Shimoi K
    Toxicology; 2010; 274(1-3):42-8. PubMed ID: 20553787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.